Chronic lymphocytic leukemia (CLL)
Board exam relevance: in 1 of more than 100 exam reports · rank 181- Synonyms
- chronic lymphatic leukemia, B-CLL, small lymphocytic lymphoma, SLL, blood cancer
- Specialty
- Internal medicine · Haematology & oncology
- Images
- Blood smear & cytology 1 · CT 1 · Histology 1 · Gross specimen 1
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (4)
Blood smear & cytology
CT
Histology
Gross specimenDefinition
Chronic lymphocytic leukemia (CLL) is a neoplasm of mature-appearing, monoclonal B lymphocytes that accumulate in the blood, bone marrow, lymph nodes, and spleen. CLL and small lymphocytic lymphoma (SLL) are regarded as one disease with different distribution. Its precursor is monoclonal B-cell lymphocytosis (MBL).
Classification
Binet stages (sites assessed: cervical, axillary, and inguinal lymph nodes, liver, spleen):
- Binet A: ≤ 2 involved sites, hemoglobin ≥ 10 g/dL, platelets ≥ 100,000/µL
- Binet B: 3–5 involved sites, hemoglobin and platelets as in stage A
- Binet C: hemoglobin < 10 g/dL or platelets < 100,000/µL, regardless of the number of involved sites
Rai stages: 0 lymphocytosis; I plus lymph node enlargement; II plus hepatomegaly or splenomegaly; III plus anemia (hemoglobin < 11 g/dL); IV plus thrombocytopenia (< 100,000/µL).
MBL according to WHO 2022: clonal B cells < 0.5 × 10⁹/L (low-count MBL) or ≥ 0.5 × 10⁹/L with total B cells < 5 × 10⁹/L (CLL/SLL-type MBL), each without other features of CLL.
Occurrence & epidemiology
CLL is the most common type of leukemia in the Western world. In Germany, according to the RKI, a good third of newly diagnosed leukemias are CLL. The average age at diagnosis is about 70 years; the disease is extremely rare in children. It is rare in Japan and China and more common in people of Ashkenazi Jewish ancestry.
Aetiopathogenesis
CD5-positive B cells acquire mutations, become continuously activated, and first form MBL; further genetic abnormalities lead to CLL. About 1–2 % of MBL progresses to CLL per year. A hereditary component is likely in some cases. Recurrent genetic abnormalities include del(13q), del(11q), del(17p), and trisomy 12, as well as TP53 mutations.
Clinical features
- Often asymptomatic initially; diagnosis frequently follows an incidental finding of lymphocytosis.
- Nonspecific complaints: fatigue, weakness, anorexia, weight loss, fever, night sweats, early satiety.
- Lymphadenopathy in more than 50 %, localized (mostly cervical and supraclavicular) or generalized; splenomegaly and hepatomegaly less common.
- Susceptibility to infection due to hypogammaglobulinemia, which develops in up to two-thirds.
- Autoimmune phenomena: autoimmune hemolytic anemia (positive direct antiglobulin test) and immune thrombocytopenia.
- Richter transformation into diffuse large B-cell lymphoma in about 2–10 %.
Diagnosis
- Blood count: absolute lymphocytosis above 5,000/µL raises suspicion of CLL.
- Flow cytometry of blood: demonstrates clonality; coexpression of CD5, CD19, CD20, and CD23 with light chain restriction (kappa or lambda) is typical.
- Bone marrow examination is not required for diagnosis; if performed, often more than 30 % lymphocytes.
- Other findings: hypogammaglobulinemia, elevated LDH, uric acid, and liver enzymes, rarely hypercalcemia.
- Cytogenetics and molecular genetics from blood (e.g., FISH for del(17p), TP53 mutation, IGHV mutation status) for risk assessment.
Treatment principles
- In asymptomatic early-stage disease, a watch-and-wait approach with regular check-ups is standard, as early treatment confers no survival benefit.
- In active disease requiring treatment, targeted agents such as BTK inhibitors or BCL2 inhibitors are now mainly used, often combined with anti-CD20 antibodies; the choice depends on genetic risk markers and comorbidities.
- Supportive measures include vaccinations, infection prophylaxis and, in severe antibody deficiency with recurrent infections, immunoglobulin replacement.
Specific treatment regimens with drugs and doses are covered in the InnereFuchs app.
Keep learning in the app
Further reading (open access)
Cross-references
More topics: Haematology & oncology
- Anemia (classification and work-up)
- Hemolytic anemias
- Acute myeloid leukemia (AML)
- Iron deficiency anemia
- Chronic myeloid leukemia (CML)
- Disseminated intravascular coagulation (DIC)
- Essential thrombocythemia
- Febrile neutropenia
- Folate deficiency
- Glucose-6-phosphate dehydrogenase deficiency (favism)
- Hemolytic uremic syndrome (HUS)
- Hemophilia
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the InnereFuchs app – free, in your browser or as an app.
Related pages: Anemia (classification and work-up) · Hemolytic anemias · Acute myeloid leukemia (AML)
Note: Learning content for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.